Elon Musk
The vision-restoring device will be implanted in humans within six to 12 months, following a successful monkey implantation that has remained active for three years, Musk said.
The tech giant will offer access to the LLM for enterprise use as regulatory scrutiny mounts over the model’s data practices and medical diagnostic claims.
The terms align with the company's brain-computer interface technologies aimed at restoring vision and enabling mind-controlled device use.
OpenAI cofounder Sam Altman says the company "is not for sale."